Cristina Ferrone

Title: Cristina Ferrone: Innovator in Cancer Treatment

Introduction

Cristina Ferrone is a prominent inventor based in Boston, MA, known for her significant contributions to cancer research and treatment. With a total of 4 patents, she has made remarkable strides in the field of chimeric antigen receptors (CAR) that target cancer cells. Her work is pivotal in developing innovative therapies that aim to improve patient outcomes.

Latest Patents

Among her latest patents, Cristina has developed methods and compositions for chimeric antigen receptors that recognize CSPG4, which are crucial in treating various diseases and disorders. Additionally, she has created CARs that target B7-H3 (CD276), further expanding the potential for effective cancer treatments. These inventions represent a significant advancement in the fight against cancer.

Career Highlights

Cristina has worked with esteemed institutions such as The General Hospital Corporation and the University of North Carolina at Chapel Hill. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Cristina has collaborated with notable colleagues, including Soldano Ferrone and Xinhui Wang. Their combined expertise has fostered an environment of innovation and discovery in cancer treatment.

Conclusion

Cristina Ferrone's work exemplifies the impact of innovative research in the medical field. Her patents and collaborations continue to pave the way for advancements in cancer therapies, showcasing her dedication to improving health outcomes for patients.